Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Vascular Physiology
• Atherosclerosis Research

Background:

• The vascular endothelium produces vasoactive substances, including nitric oxide (vasodilator) and endothelin (vasoconstrictor).
• Atherosclerosis disrupts the balance of these endothelium-derived factors.
• Endothelial dysfunction is a critical factor in atherosclerosis development.

Purpose of the Study:

• To highlight the disturbed balance of endothelium-derived factors in atherosclerosis.
• To underscore the role of endothelin and nitric oxide in vascular health and disease.
• To identify endothelial dysfunction as a therapeutic target in atherosclerosis.

Main Methods:

• Review of existing literature on endothelial function and vasoactive substances.
• Analysis of the roles of nitric oxide and endothelin in vascular homeostasis and pathology.
• Discussion of the impact of cardiovascular risk factors on endothelial function.

Main Results:

• Endothelin counteracts the beneficial effects of nitric oxide, promoting vasoconstriction and hypertrophy.
• Endothelial dysfunction in atherosclerosis is influenced by genetic and cardiovascular risk factors.
• Impaired endothelial function is a crucial contributor to atherosclerotic disease progression.

Conclusions:

• Restoring the balance of vasoactive substances is a potential therapeutic strategy.
• Endothelial dysfunction represents a significant target for intervention in atherosclerosis.
• Pharmacotherapy efficacy for improving endothelial function is patient-specific, depending on risk factors.